Specialty Pharmacy

Enasidenib, an oral inhibitor for relapsed or refractory acute myeloid leukemia, shows promise in achieving a complete response with hematologic improvement.

New treatment strategies for rheumatoid arthritis led to a reduction in congestive heart failure and cardiovascular mortality after the year 2000.

Combining old and new technology may provide superior oncologic outcomes for patients with resectable lung cancer.

Study will compare the pharmacokinetics and clinical outcomes between Humira biosimilar and its reference product in the treatment of moderate-to-severe chronic plaque psoriasis.

Top news of the day from across the health care landscape.

Increased efforts in prevention and treatment for HIV show promise in high-burden regions.

Pharmacists crack the top 5 of most competitive in-demand jobs with 6-figure salaries.

The upcoming National Association of Specialty Pharmacy conference will focus on the evolution of the industry.

PCMA report suggests that DIR fees will save $308.2 billion between 2017 and 2026, while critics say the report is misleading.

Discovery may lead to new immunotherapies for aggressive breast cancer.

Top news of the day from across the health care landscape.

More than half of survey respondents with HIV reported concerns about possible drug-drug interactions.

Long-acting HIV medications could solve problems with adherence, reduce costly laboratory tests to monitor their efficacy, and bring down drug costs.

Technique offers improved survival in patients with advanced, inoperable stage 3 non-small cell lung cancer.

Top articles of the week from Specialty Pharmacy Times.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

HIV patients lack crucial peroxisomal proteins in the brain.

Top news of the day from across the health care landscape.

Dampened cytokine interaction may indicate asymptomatic glioma.

Every 10 cm increase in waist size found to increase risk of high-grade prostate cancer by 13%.

Approximately 325 million individuals are living with hepatitis worldwide.

Those who battled hepatitis C recount their journey to spread awareness on World Hepatitis Day.

The annual meeting of the National Association of Specialty Pharmacy will take place this September in Washington, DC.

Response rate higher among patients with HIV treated with dolutegravir compared with lopinavir/ritonavir.

Interaction between patients with cancer during chemotherapy may increase 5-year survival.

Top news of the day from across the health care landscape.

World Hepatitis Day brings awareness to the burden of hepatitis, which is a leading cause of death worldwide.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how operating a specialty pharmacy associated with a retail pharmacy can be beneficial.